Wednesday, 01 October 2014
|NZX : PEB|
30 Sep 14 00:00
Pacific Edge is a New Zealand based biomedical company specialising in the discovery and commercialisation of diagnostic and prognostic technology for the early detection and monitoring of cancer.
Two products have recently completed successful clinical trials, bladder cancer detection and colorectal cancer prognosis (CRC). The bladder cancer technology Cxbladder® has been released to the market in Australia and New Zealand. CRC is being readied for commercial release. Pipeline products still in development include gastric and endometrial cancers and melanoma.
Cxbladder® is a non-invasive, accurate test that enables the early detection of bladder cancer from a small volume of urine providing general practitioners and urologists with a quick, cost effective and accurate measure of the presence of the cancer and provides urologists with the opportunity to reduce their reliance on the need for invasive tests such as cystoscopy.
The Company is commercialising its products from its new diagnostic laboratory in New Zealand and plans further commercialisation in the US and Europe as a centralised diagnostic service through its own facilities or as a turn-key solution, licensed to selected partners. Pacific Edge has plans for further studies in key markets to engage leading medical and urological opinion leaders who will be vital to success in new markets.
|Issuer:||Pacific Edge Limited|
|Solicitor:||Anderson Lloyd Caudwell Dunedin|
|Registry:||LINK MARKET SERVICES LIMITED|
|Auditor:||Pricewaterhouse Coopers Dunedin|
|Settlement:||NZCDC Settlement System|
|52 wk High:||1.7600|
|52 wk Low:||0.4900|
Pacific Edge Limited
87 St David Street
22:00 | 30/9/14
Discover Magazine (blog)
Back in the early to mid-2000s, reports of the resurgence of the Ivory Billed Woodpecker—one of the largest woodpeckers in the world, thought to be on the edge of extinction—began circulating. It was a big deal in the ... Though the genetic data on ... more»
18:48 | 30/9/14
Some lugged metal road barricades into positions on the edge of crowds, presumably to slow a police advance. In at least one ... Financial fallout from the turmoil has been limited so far as investors gauge how severe Beijing's response might be. Hong ... more»
15:47 | 30/9/14
ASX 200 edges higher in choppy trade, China PMI hovers at 50.2 ... Aurizon Ltd lost 0.9 percent to 12-month lows of A$4.46 after the rail haulage group warned a smaller-than- xpected government cap on revenue of A$4.02 billion it can generate from its ... more»
10:22 | 30/9/14
Wall Street Journal
"Hong Kong is China's most visible international city and its most global city in terms of capital flows and in terms of using it as a business base, so anything that happens in Hong Kong--even if it's limited to Hong Kong--still casts a very long ... more»
03:59 | 30/9/14
This will not only help improve shareholders' return but will also allow the company to gain a competitive edge against peers like Norfolk Southern Corporation (NSC - Analyst Report), Canadian Pacific Railway Limited (CP - Analyst Report) and Union ... more»
NOTICE OF CHANGE IN ISSUED CAPITAL STOCK - ORDINARY SHARES
Pursuant to Listing Rule 7.3.5
Company: Pacific Edge Limited ISIN NZPEBE0002S1
Date: 5 July 2013
Date of Is more»
NOTICE OF APPOINTMENT OF INDEPENDENT DIRECTOR
Pursuant to Listing Rule 3.3
Date: 4 July 2013
Company: Pacific Edge Limited
Pacific Edge Limited is pleased to announce that more»
Please find attached the 2013 Annual Report.
End CA:00237882 For:PEB Type:ANNREP Time:2013-06-27 10:47:29 more»
See attached presentation
End CA:00237343 For:PEB Type:ADDRESS Time:2013-06-13 09:52:00 more»
PRELIMINARY FULL YEAR DISCLOSURE
Pacific Edge Limited
Year End 31 March 2013
FY2013 Results Summary
- Sales and marketing of Cxbladder launched in the USA - the world''s larg more»
There are currently no comments on this topic.
Be the first person to Add a Comment...
You must be a registered user to post a comment: REGISTER NOW
If you are already registered, please LOGIN NOW